PREGNANCY: SINGULAIR
should be used during pregnancy only if clearly needed. Available data from
published prospective and retrospective cohort studies with montelukast use in
pregnant women evaluating major birth defects have not established a
drug-associated risk. Available studies have methodologic limitations,
including small sample size, in some cases retrospective data collection, and
inconsistent comparator groups.
NURSING MOTHERS: It is not known if SINGULAIR is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when SINGULAIR is given to a nursing mother.
Other Services
Country
Account